drugset / Trial / NCT05788588

A Phase Ⅲ Study of HR19006 Injection in Postsurgical Parenteral Nutrition

NCT05788588 ↗

Phase 3 Unknown 240 enrolled Fujian Shengdi Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

This is a phase Ⅲ, multi-center, randomized, single-blind, parallel controlled with active drug, confirmatory study, and the purpose of the study is to evaluate the efficacy and safety of HR190006 for postoperative parenteral nutrition via central venous catheter.

Timeline

Start
2023-04-28
Primary completion
2023-11-30
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject HR19006 Unknown — Intravenous

Indications

No indication recorded.